dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Lecour, Sandrine |
dc.contributor.author | Andreadou, Ioanna |
dc.contributor.author | Bøtker, Hans Erik |
dc.contributor.author | Davidson, Sean M |
dc.contributor.author | Heusch, Gerd |
dc.contributor.author | Ruiz Meana, Marisol |
dc.date.accessioned | 2022-06-13T13:21:41Z |
dc.date.available | 2022-06-13T13:21:41Z |
dc.date.issued | 2021-09-13 |
dc.identifier.citation | Lecour S, Andreadou I, Bøtker HE, Davidson SM, Heusch G, Ruiz-Meana M, et al. IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action. Basic Res Cardiol. 2021 Sep 13;116:52. |
dc.identifier.issn | 1435-1803 |
dc.identifier.uri | https://hdl.handle.net/11351/7674 |
dc.description | Cardioprotección; Desarrollo de fármacos; Infarto |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Basic Research in Cardiology;116 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Reperfusió miocardíaca |
dc.subject | Cor - Malalties - Tractament |
dc.subject | Cor - Malalties - Prevenció |
dc.subject.mesh | Myocardial Infarction |
dc.subject.mesh | /prevention & control |
dc.subject.mesh | Reperfusion Injury |
dc.title | IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s00395-021-00893-5 |
dc.subject.decs | infarto de miocardio |
dc.subject.decs | /prevención & control |
dc.subject.decs | daño por reperfusión |
dc.relation.publishversion | https://doi.org/10.1007/s00395-021-00893-5 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Lecour S] Department of Medicine, Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, Cape Town, South Africa. [Andreadou I] Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece. [Bøtker HE] Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark. [Davidson SM] The Hatter Cardiovascular Institute, University College London, London, UK. [Heusch G] Institute for Pathophysiology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany. [Ruiz-Meana M] Grup de Recerca en Malalties Cardiovasculars, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 34515837 |
dc.identifier.wos | 000698137400001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01196 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |